NanoViricides, Inc.NNVCNYSE
Loading
SG&A Expense Growth AcceleratingAccelerating
Percentile Rank79
3Y CAGR-9.8%
5Y CAGR+8.8%
Year-over-Year Change
Year-over-year SG&A expense growth
3Y CAGR
-9.8%/yr
Quarterly compound
5Y CAGR
+8.8%/yr
Recent deceleration
Percentile
P79
Within normal range
vs 5Y Ago
1.5x
Solid growth
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 22.13% |
| Q3 2025 | -14.34% |
| Q2 2025 | -2.97% |
| Q1 2025 | 7.11% |
| Q4 2024 | -26.89% |
| Q3 2024 | 2.11% |
| Q2 2024 | 74.31% |
| Q1 2024 | 13.56% |
| Q4 2023 | 8.13% |
| Q3 2023 | -26.00% |
| Q2 2023 | 24.20% |
| Q1 2023 | -7.33% |
| Q4 2022 | 30.13% |
| Q3 2022 | -17.95% |
| Q2 2022 | 16.60% |
| Q1 2022 | -19.18% |
| Q4 2021 | 27.90% |
| Q3 2021 | 64.15% |
| Q2 2021 | -51.19% |
| Q1 2021 | -19.45% |
| Q4 2020 | 14.54% |
| Q3 2020 | -8.83% |
| Q2 2020 | -45.68% |
| Q1 2020 | 126.28% |
| Q4 2019 | 23.12% |
| Q3 2019 | -13.13% |
| Q2 2019 | -24.68% |
| Q1 2019 | 8.60% |
| Q4 2018 | 13.34% |
| Q3 2018 | -38.84% |
| Q2 2018 | -26.14% |
| Q1 2018 | 37.88% |
| Q4 2017 | -6.28% |
| Q3 2017 | 8.87% |
| Q2 2017 | -6.53% |
| Q1 2017 | 1.92% |
| Q4 2016 | 4.89% |
| Q3 2016 | 10.55% |
| Q2 2016 | -8.84% |
| Q1 2016 | 4.58% |